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Abstract
Introduction
The  purpose  of  this  study  was  to  assess  crude,  age-
adjusted,  and  risk-factor–specific  prevalences  of  self-
reported  prediabetes  and  to  identify  factors  associated 
with self-reported prediabetes in an adult population.
Methods
Data were collected through questionnaires completed 
by  a  racially  diverse  sample  of  diabetes-free  adult  par-
ticipants in the statewide community-based wellness and 
diabetes awareness program in New York State during 
2006 (N = 2,572). Prediabetes was determined by the affir-
mative answer to the question, “Have you ever been told 
by a doctor that you have prediabetes?”
Results
The overall crude prevalence of self-reported prediabetes 
was 9.1%, and the age-adjusted prevalence was 7.6%. The 
age-adjusted prevalence of prediabetes was significantly 
lower among non-Hispanic blacks (4.2%) and significantly 
higher among American Indians (22.4%), compared with 
the  prevalence  among  non-Hispanic  whites  (7.3%).  The 
prevalence  of  self-reported  prediabetes  was  uniformly 
higher among older (aged ≥45 years) adults than younger 
(aged <45 years) adults, overall and in each racial/ethnic 
group. In all age and racial/ethnic groups, the prevalence 
significantly increased with the number of additional risk 
factors. The best fit multivariate logistic regression model 
identified  that  self-reported  prediabetes  was  associated 
with family history of diabetes (odds ratio [OR], 3.65), body 
mass index 25.0 kg/m2 or higher (OR, 2.79), age 45 years or 
older (OR, 2.77), and having health insurance (OR, 2.38).
Conclusion
This study found that adults who were at high risk for 
diabetes  and  had  health  insurance  were  more  likely  to 
report  having  prediabetes.  Community-based  diabetes 
prevention needs to consider strategies to increase detec-
tion of prediabetes in high-risk uninsured people and to 
raise general awareness of prediabetes.
Introduction
Type  2  diabetes,  which  affects  nearly  10%  of  the  US 
adult population, is a major cause of morbidity, mortal-
ity, and decreased quality of life, causing high economic 
costs (1,2). The prevalence of type 2 diabetes has increased 
considerably during the past few decades, and the trend is 
likely to continue through the middle of this century (3,4). 
An estimated 1 in 3 Americans born in 2000 will develop 
diabetes in his or her lifetime (5). All people with type 2 
diabetes  go  through  a  clinical  phase  called  prediabetes 
(6). Prediabetes is characterized by blood glucose levels 
that are higher than normal but not in the diabetic range 
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and is defined by having impaired fasting glucose (IFG) or 
impaired glucose tolerance (IGT) or both (7). IFG is defined 
by a fasting plasma glucose level of 100 to 125 mg/dL (5.6 
to 6.9 mmol/L), and IGT is defined by a 2-hour plasma 
glucose level of 140 to 199 mg/dL (7.8 to 11.1 mmol/L) after 
administration of 75 g of oral glucose (7). These ranges of 
plasma glucose levels signify the threshold at which the 
risk of type 2 diabetes increases sharply (7). Prediabetes is 
a serious health condition. People with prediabetes have 
10 times the risk of developing type 2 diabetes within 7 
years compared with people whose glucose level is in the 
normal range (8). Prediabetes is also an independent risk 
factor for cardiovascular disease (9,10).
Scientific evidence suggests that people with prediabe-
tes can delay or reverse the progression to type 2 diabetes. 
Randomized clinical trials around the world found that 
interventions with pharmacologic agents (11,12) or lifestyle 
changes (12-15) can delay or prevent the onset of type 2 dia-
betes in adults with prediabetes. The Diabetes Prevention 
Program  (DPP),  which  involved  racially  and  ethnically 
diverse  adults  from  27  sites  across  the  United  States 
(16),  provides  the  most  relevant  evidence  for  American 
adults. The DPP demonstrated that in overweight adults 
with prediabetes, lifestyle modification including modest 
weight loss, dietary change, and increased physical activ-
ity reduced the risk of developing type 2 diabetes by 58%, 
while drug intervention with metformin reduced the risk 
by 31% (12). Lifestyle modification was highly effective for 
all age, sex, and racial/ethnic groups (12).
Prediabetes  can  only  be  detected  through  routine  or 
opportunistic glucose screening. The American Diabetes 
Association  (ADA)  recommends  periodic  glucose  screen-
ing for people aged 45 years or older, particularly those 
with a body mass index (BMI) of 25.0 kg/m2 or more (17). 
The ADA also recommends screening for people younger 
than 45 who have a BMI of 25.0 kg/m2 or higher if they 
have another risk factor for type 2 diabetes, such as fam-
ily  history  of  diabetes  or  being  a  member  of  high-risk 
racial/ethnic groups including African American, Hispanic, 
American Indian, and Asian/Pacific Islander (17). Other 
medical professional organizations, government agencies, 
and expert bodies also have age- and risk-based, distinc-
tive recommendations for glucose screening (18,19).
According  to  the  National  Health  and  Nutrition 
Examination  Survey  (NHANES),  which  examines  bio-
logical samples of respondents, 26% of US adults aged 20 
years or older (20) and 7% of US adolescents aged 12 to 
19 (21) had prediabetes as measured by IFG. The preva-
lence of prediabetes increased with age, and significant 
differences were found by sex and race/ethnicity; men and 
boys  had  higher  prevalence  than  did  women  and  girls, 
and Mexican Americans had higher prevalence than did 
non-Hispanic whites (20,21). At least 54 million adults (5) 
and 1.9 million adolescents (21) in the United States are 
estimated to have prediabetes.
Despite  the  extent  of  prediabetes  in  the  US  popula-
tion, scant data are available for the prevalence of self-
reported physician-diagnosed prediabetes. Since 2004, the 
Behavioral Risk Factor Surveillance System (BRFSS) tele-
phone survey has been coding “prediabetes or borderline 
diabetes” as an unsolicited answer option to the question 
for diagnosed diabetes (22). The 2006 data indicate that 
the nationwide prevalence of self-reported prediabetes or 
borderline diabetes in adults aged 18 years or older was 
1.0% (23). The BRFSS questionnaire, however, does not 
independently  and  specifically  ask  respondents  if  they 
have been diagnosed with prediabetes.
This  study  assessed  the  prevalence  of  self-reported 
prediabetes in diabetes-free adults by using a structured 
questionnaire. The study was conducted to provide crude 
and  age-adjusted  prevalences  of  self-reported  prediabe-
tes for the overall population and population strata. To 
examine relationships between self-reported prediabetes 
and its related risk factors, both descriptive and multi-
variate logistic regression analyses were conducted. This 
study aims to provide baseline information on the extent 
of  self-reported  prediabetes  in  an  adult  population  and 
to  facilitate  the  formulation  of  community-based  public 
health strategies to increase awareness and detection of 
prediabetes, as part of the national effort to translate the 
DPP results into practice.
Methods
Data  for  this  study  were  collected  from  diabetes-free 
adults aged 18 years or older who participated in a com-
munity-based wellness and diabetes awareness program in 
New York State sponsored by the state health department. 
A total of 15 regional core organizations and 146 partner 
organizations took part in the program to assure geographic 
coverage of all 62 counties in the state. Participants were 
volunteers  who  responded  to  program  announcements VOLUME 6: NO. 2
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made by local partner organizations through various out-
reach channels. The only criteria for participation were 
being age 18 years or older and having no prior diagnosis 
of diabetes. From January 1 through December 31, 2006, 
all participants were asked to complete a questionnaire at 
registration. The New York State Department of Health 
Institutional Review Board reviewed and approved this 
study. No identifiable personal information was requested 
to ensure complete anonymity. The questionnaire was a 
single-page form, written at a sixth-grade reading level 
and made available in both English and Spanish.
The  questions  included  were  age,  sex,  race/ethnicity, 
physician-diagnosed  prediabetes,  gestational  diabetes, 
BMI, family history of diabetes, tobacco product use, and 
health insurance coverage. These questions were selected 
on the basis of established risks for prediabetes and type 
2 diabetes, availability of tested and widely used survey 
questionnaires, and appropriateness for the diverse popu-
lation. Diagnosed prediabetes was assessed through the 
question, “Have you ever been told by a doctor that you 
have prediabetes?” The technical terms IFG and IGT or 
the colloquial “borderline diabetes” were not used because 
prediabetes  is  the  preferred  term  for  provider-patient 
communication and health education (24,25). Gestational 
diabetes was assessed if the respondent had diabetes only 
during pregnancy. For BMI information, the respondent 
was instructed to select 1 of the 4 letter-coded sections 
(A to D) in the height and weight chart where his or her   
height and weight fell. The sections were designed to cor-
respond to underweight (BMI <18.5 kg/m2), normal weight 
(BMI,  18.5-24.9  kg/m2),  overweight  (BMI,  25.0-29.9  kg/
m2), and obese (BMI ≥30.0 kg/m2). Family history of dia-
betes specifically referred to diagnosed diabetes in mother, 
father,  sister,  or  brother.  The  tobacco-use  question  was 
phrased as “Do you use any tobacco products regularly?” 
The health insurance coverage question was, “Do you have 
a health insurance plan that covers most of your health 
care costs?”
A total of 2,572 people completed the entire question-
naire. I obtained the overall and stratum-specific crude 
prevalence of prediabetes. For the purpose of comparison, 
I  age-adjusted  the  overall  and  stratum-specific  preva-
lence to the 2000 New York State Census population by 
using the direct method, with age categories of 44 years 
or younger, 45 to 64 years, and 65 years or older. The 
race/ethnicity prevalence analysis was limited to 4 groups 
(non-Hispanic  white,  non-Hispanic  black,  Hispanic,  and 
American  Indian)  that  had  sufficient  sample  size  (N  ≥ 
50) for stable prevalence estimation and age-adjustment 
calculation. I calculated the 95% confidence intervals by 
using the Fisher exact method.
In  the  next  analysis,  I  grouped  the  study  population 
into age- and race/ethnicity-specific groups on the basis of 
the known risk for prediabetes. The population was first 
separated by age (aged ≥45 years and <45 years), then 
divided into non-Hispanic white and minorities (Hispanics 
and/or nonwhites). These categories were further strati-
fied into mutually exclusive and exhaustive combinations 
of 2 additional risk factors: BMI 25.0 kg/m2 or higher and 
family history of diabetes. I obtained the prevalence and 
95% confidence intervals of self-reported prediabetes for 
all strata. I calculated the χ2 trend statistic for prevalence 
by combined risk factors (0, 1, or 2) for each demographic 
cluster.
Finally,  I  constructed  logistic  regression  models  to 
identify factors associated with self-reported prediabetes. 
First, all independent variables (age, sex, race/ethnicity, 
BMI, family history, gestational diabetes, tobacco use, and 
health  insurance  coverage)  were  entered  in  the  model, 
and  then  the  backward  stepwise  selection  method  was 
used to remove nonsignificant variables. For the purpose 
of demographic control, I forced age, sex, and race/ethnic-
ity variables to remain in the initial model. I also tested 
2 interaction terms: insurance status by race and BMI by 
race. I continued the variable removal process to obtain 
the best fit model, this time by examining the Hosmer-
Lemeshow  goodness-of-fit  statistic.  I  present  the  initial 
and best fit models with the odds ratios, 95% confidence 
intervals (CIs) of the odds ratios, and their significance.
Results
The age distribution of the sample was 32.7% for the 
group aged 18 to 44 years, 37.7% for 45 to 64 years, and 
29.5%  for  65  years  and  older.  Approximately  41%  of 
the sample were racial/ethnic minorities, including non-
Hispanic black (24.1%), Hispanic (9.1%), American Indian 
(3.3%), Asian and Pacific Islander (1.2%), and mixed or 
other races (2.9%). In New York State, approximately 35% 
of the adult population (aged ≥18 years) are racial/ethnic 
minorities.
The overall crude prevalence of self-reported prediabetes VOLUME 6: NO. 2
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in this sample was 9.1% (95% CI, 8.0-10.2). The prevalence 
increased with age (Table 1); the age-adjusted overall prev-
alence was 7.6% (95% CI, 6.6-8.7). After age adjustment, 
American  Indians  had  higher  rates  of  prediabetes  than 
did  non-Hispanic  whites,  and  non-Hispanic  blacks  had 
lower rates of prediabetes than did non-Hispanic whites. 
Prediabetes was significantly more prevalent among adults 
with BMI of 25 kg/m2 or higher. Prevalence was also higher 
in adults who had a family history of diabetes and in adults 
with health insurance. No significant difference between 
men and women was observed (Table 1).
In  the  analysis  of  risk-factor–specific  prevalence  of 
self-reported  prediabetes,  several  general  trends  were 
observed. The prevalence was higher in the older group 
(aged ≥45 years) compared with the younger group (aged 
<45 years) (11.3% vs 4.4%) for the study population over-
all. Higher prevalence in the older group compared with 
the younger group was also observed among non-Hispanic 
whites  (12.4%  vs  3.1%)  and  among  minorities  (9.4%  vs 
5.6%). Within each age and racial/ethnic subgroup, preva-
lence increased significantly with each additional risk fac-
tor. The trend was exponential rather than linear, as the 
increase of prevalence accelerated from 1 risk to 2 risks 
(Table 2).
In the logistic regression analysis, the initial model with 
demographic control variables found that people who had 
a family history of diabetes, BMI ≥25.0 kg/m2, age 45 years 
or older, and health care coverage were 2.3 to 3.6 times 
more likely to have self-reported prediabetes than were 
those who did not have those properties. In terms of race 
and ethnicity, American Indians were approximately 3.6 
times more likely to report prediabetes than was any other 
race category, while for non-Hispanic blacks the probabil-
ity of reporting prediabetes was almost half that of other 
racial groups. This model, however, had a poor overall fit, 
indicated  by  the  Hosmer  and  Lemeshaw  goodness-of-fit 
test statistic (χ2 = 10.9, df = 8, P = .2). The interaction 
terms did not contribute to any significant improvement 
of the model. The best fit model (χ2 = 2.18, df = 7, P = .94) 
removed the race and sex variables (Table 3).
Discussion
The  findings  of  this  study  showed  a  significant  asso-
ciation between health insurance coverage and diagnosed 
prediabetes. Access to affordable health care appears to 
be  a  prerequisite  for  being  diagnosed  with  prediabetes. 
Despite differences in the eligibility criteria for screening, 
the  ADA,  the  US  Preventive  Services  Task  Force,  and 
other  influential  US  medical  organizations  and  govern-
ment  agencies  recommend  practice-based,  in-clinic  glu-
cose screening (18,19,26). Mass community-based glucose 
screening is discouraged because the number of diabetes 
and prediabetes cases diagnosed is small (27) and its stan-
dardized  methods  and  cost-effectiveness  have  not  been 
established (18). People without health insurance are less 
likely to have routine checkups, and their lower use of 
nonemergency clinical facilities may reduce their chances 
of receiving opportunistic glucose screening (28). Access 
to affordable health care is critical for both diagnosis of 
prediabetes and subsequent lifestyle and pharmacologic 
intervention to prevent progression to type 2 diabetes.
American Indians’ high prevalence of self-reported pre-
diabetes was notable. American Indians have been recog-
nized for their biological susceptibility to abnormalities in 
glucose metabolism (29). More rigorous glucose screening 
starting at a younger age and increased awareness of pre-
diabetes for this population may have contributed to the 
high prevalence. The Indian Health Service recommends 
that American Indian adults aged 18 years or older should 
be tested for prediabetes annually if they have 1 or more 
diabetes risk factors, and if no risk factors exist, testing 
should begin at age 35 and be repeated a minimum of 
every 3 years (30). In fact, the prevalence of self-reported 
prediabetes among American Indian adults younger than 
45 years was 21%, which was 6 to 10 times higher than 
that of other racial/ethnic groups in the same age range 
(data not shown).
The lower prevalence of self-reported prediabetes among 
non-Hispanic  blacks  compared  with  that  among  non-
Hispanic  whites  is  consistent  with  previous  findings. 
Studies  using  NHANES  data  have  reported  uniformly 
lower  prevalence  of  IFG,  IGT,  and  prediabetes  among 
non-Hispanic black adults and adolescents compared with 
that among non-Hispanic whites (20,21,31). One possible 
hypothesis is that type 2 diabetes progresses more aggres-
sively in blacks, resulting in a relatively short prediabetic 
phase.  NHANES  studies  reported  a  higher  prevalence 
of  prediabetes  among  Mexican  Americans,  but  in  this 
study, Hispanics had a slightly lower prevalence than did 
non-Hispanic whites. New York State Hispanics mostly 
originate from the Caribbean and Central America (32), 
so a direct comparison with Mexican Americans may not VOLUME 6: NO. 2
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be relevant. Linguistic or cultural barriers may limit the 
rate of glucose screening among this group, resulting in 
a  lower  prevalence  of  diagnosed  prediabetes.  The  asso-
ciation of race/ethnicity with diagnosed prediabetes was 
only  marginally  significant.  Further  research  is  needed 
to understand the role of race/ethnicity in the diagnosis of 
prediabetes.
There  are  limitations  in  this  study.  The  precision  of 
estimate  was  compromised  by  the  small  sample  size. 
Because the study was based on self-report, biases may 
have resulted from respondents’ recall. Some respondents 
probably have had blood glucose in the prediabetic range 
but were not informed of their prediabetes status by their 
physicians.  Most  laboratory  reports  use  the  terms  IFG 
and IGT to indicate prediabetes, so patients need to be 
educated  by  their  physicians  about  what  these  terms 
mean. Some physicians probably choose to use “borderline 
diabetes” or “a touch of sugar” to inform patients about the 
glucose abnormality.
In the United Kingdom, physicians who lack knowledge 
and skills to promote lifestyle changes, have large workloads, 
and believe health promotion is not a role of physicians are 
less likely to discuss prediabetes with their patients (33-
35). Little is known about how US physicians inform and 
educate their patients about prediabetes. This study did not 
collect information regarding specialty and practice type of 
the physicians that respondents were seeing.
Another source of bias is the healthy volunteer effect. 
This sample, however, was older and included more people 
who  were  obese  or  were  members  of  high-risk  minor-
ity  populations  than  the  state’s  adult  population  with-
out diagnosed diabetes, according to 2006 BRFSS data. 
Awareness  of  prediabetes  and  participation  in  glucose 
screening among the sample might be higher than that of 
the state’s general adult population.
This study provides a knowledge base of the extent of 
self-reported prediabetes and its associations with selected 
risk  factors  in  racially  diverse  adults  in  a  community 
setting. This type of information is highly desirable for 
the formulation of community-based strategies to detect 
prediabetes  and  prevent  type  2  diabetes.  This  study 
demonstrates that people who lack health insurance are 
less likely to report prediabetes than are those who have 
insurance. As efforts to translate the findings of the DPP 
into  community  settings  continues,  there  is  an  urgent 
need  to  increase  general  awareness  of  prediabetes  and 
allocate public health resources to systematically identify 
and  follow  uninsured  or  underinsured  high-risk  people 
with prediabetes. In addition, more research is needed to 
understand the roles of race and ethnicity and physician-
patient communication in the diagnosis of prediabetes.
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Tables
Table 1. Crude and Age-Adjusted Prevalence (%) of Self-Reported Physician-Diagnosed Prediabetes in Adults Participating in 
Diabetes Awareness Program, New York State, 2006
Category No.
Crude Age-Adjusted
% (95% CI) P value % (95% CI) P value
Age, y
< 82 . (.-6.0)  Ref — —
-6 970 0.8 (8.9-.0) <.00 — —
>6 760 2.0 (9.8-.) <.00 — —
Sex
Male 28 8. (6.-0.)
.
6. (.7-8.8)
.2
Female ,9 9. (8.-0.7) 7.9 (6.8-9.2)
Race/ethnicitya
Non-Hispanic white , 9.9 (8.-.)  Ref 7. (6.0-8.7)  Ref
Non-Hispanic black 69 .7 (.2-6.7) <.00 .2 (2.8-6.) .008
Hispanic 2 6. (.6-0.) .09 6.0 (.-9.8) .
American Indian 8 2. (.0-.0) <.00 22. (.0-2.7) <.00
Body mass index, kg/m2
<2.0 97 .2 (.0-.7)  Ref . (2.-.8) Ref
2.0-29.9 82 8. (6.-0.2) <.00 . (.-6.) <.00
≥30.0 77 6.2 (.6-9.0) <.00 . (.7-6.8) <.00
Family history of diabetes
Yes ,069 . (.-7.7)
<.00
. (.-.7)
<.00
No ,0 . (.-.7) . (2.7-.6)
Gestational diabetes
Yes 6 7.7 (2.-7.0)
.6
7.7 (2.-7.0)
.92
No ,879 9. (8.-0.8) 8.0 (6.8-9.)
Regular tobacco use
Yes 7 7.8 (.-.)
.9
8.6 (6.0-2.)
.
No 2,2 9. (8.-0.) 7. (6.-8.7)
Health insurance
Yes 2,22 9.8 (8.6-.)
.00
8.2 (7.-9.)
.00
No 0 . (2.-6.8) .8 (2.-6.)
All adults 2,72 9. (8.0-0.2) — 7.6 (6.6-8.7) —
 
Abbreviations: CI, confidence interval; Ref, reference group. 
a Sample size for Asian and Pacific Islanders, mixed races, and other races was too small (<0) to provide stable prevalence estimates and age-adjustment 
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Table 2. Prevalence of Self-Reported Physician-Diagnosed Prediabetes in Adults Participating in Diabetes Awareness 
Program, by Age, Race/Ethnicity, and Combination of Risk Factors, New York State, 2006
Combination of Risk Factors
All Races Non-Hispanic Whites Racial/Ethnic Minoritiesa
No. % (95% CI) No. % (95% CI) No. % (95% CI)
Age ≥45 y ,70 . (9.9-2.9) , 2. (0.-.) 66 9. (7.2-2.0)
No added risks 26 . (2.0-.7) 08 .2 (2.-7.) 8 .7 (0.2-6.0)
BMI ≥25.0 kg/m2 88 8.0 (.9-0.) 79 8.7 (6.-2.0) 209 6.7 (.7-.0)
Family history of diabetes 220 9.6 (6.0-.2)  0.6 (6.-6.9) 79 7.6 (2.8-.8)
BMI ≥25 kg/m2 and family history of diabetes 96 22.8 (9.2 -26.7) 286 26.9 (2.9-2.) 20 7. (2.-22.9)
P valueb <.00 <.00 <.00
Age < y 82 . (.-6.0) 7 . (.7-.) 2 .6 (.7-8.)
No added risks 207 0 (0-.8) 0 0 (0-2.8) 77 0 (0-.7)
BMI ≥25 kg/m2 282 2. (0.8-.6)  .0 (0.8-7.) 7 . (0.2-.8)
Family history of diabetes 2 . (.-9.) 9 . (.-.) 62 .2 (0.-.2)
BMI ≥25  kg/m2 and family history of diabetes 22 .2 (7.-6.0) 9 6. (2.-.) 9 . (9.0-2.)
P valueb <.00 .00 <.00
 
Abbreviations: CI, confidence interval; BMI, body mass index. 
a Includes nonwhite races and Hispanics. 
b P values were determined by χ2 test for linear trend.
Table 3. Logistic Regression Models for Factors Associated With Self-Reported Physician-Diagnosed Prediabetes in Adults 
Participating in Diabetes Awareness Program, New York State, 2006
Variable
Model With Demographic Controlsa Best Fit Modelb
OR (95% CI) P value OR (95% CI) P value
Family history of diabetes
Yes .6 (2.6-.8)
<.00
.6 (2.70-.92)
<.00
No  [Reference]  [Reference]
Body mass index, kg/m2
≥25 2.78 (.9-.97)
<.00
2.79 (.96-.97)
<.00
<2  [Reference]  [Reference]
Age, y
≥45 . (2.2-.6)
<.00
2.77 (.9-.00)
< .00
<  [Reference]  [Reference]
 
a The Hosmer-Lemeshow goodness-of-fit test was used to assess overall fit (χ28 = 0.9, P = .2). 
b The Hosmer-Lemeshow goodness-of-fit test was used to assess overall fit (χ27 = 2.2, P = .9). 
c Race and sex were removed in the best fit model through the backward stepwise selection method. These variables were found to be nonsignificant based 
on the probability of a likeihood-ratio statistic.
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Variable
Model With Demographic Controlsa Best Fit Modelb
OR (95% CI) P value OR (95% CI) P value
Health care coverage
Yes 2.2 (.28-.22)
.006
2.8 (.-.8)
.00
No  [Reference]   [Reference]
Racec
Non-Hispanic white 0.96 (0.96-.77) .90
—
Non-Hispanic black 0. (0.20-0.99) .08
Hispanic 0. (0.22-.) .9
American Indian .6 (.6-9.09) .00
All other  [Reference] —
Sexc
Male .22 (0.86-.7)
.66 —
Female  [Reference]
 
a The Hosmer-Lemeshow goodness-of-fit test was used to assess overall fit (χ28 = 0.9, P = .2). 
b The Hosmer-Lemeshow goodness-of-fit test was used to assess overall fit (χ27 = 2.2, P = .9). 
c Race and sex were removed in the best fit model through the backward stepwise selection method. These variables were found to be nonsignificant based 
on the probability of a likeihood-ratio statistic.
Table 3. (continued) Logistic Regression Models for Factors Associated With Self-Reported Physician-Diagnosed Prediabetes 
in Adults Participating in Diabetes Awareness Program, New York State, 2006